Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,308
Views
0
CrossRef citations to date
0
Altmetric
Oncology
The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective
Vladislav Berdunova PHMR Ltd, London, UKCorrespondence[email protected]
https://orcid.org/0000-0002-5743-2184View further author information
Ewan Lawsa PHMR Ltd, London, UK
https://orcid.org/0000-0001-6088-2787View further author information
Gebra Cuyun Carterb Exact Sciences, Redwood City, CA, USAView further author information
, Roger Luob Exact Sciences, Redwood City, CA, USAView further author information
, Christy Russellb Exact Sciences, Redwood City, CA, USAView further author information
, Sara Campbellb Exact Sciences, Redwood City, CA, USAView further author information
, Jeremy Forcec Duke University School of Medicine, Durham, NC, USA;d Duke Cancer Institute, Durham, NC, USAView further author information
& Yara Abdoue UNC School of Medicine, Chapel Hill, NC, USAView further author information
show all
Pages 973-990
|
Received 23 Mar 2023, Accepted 10 Jul 2023, Published online: 07 Aug 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.